Company / Income Tax
Immunovant, Inc. Income Tax History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$891.0K
FY2024
5-year range
-$358.0K / $891.0K
FY2020-FY2024
Trend
+57.1%
vs FY2023
Sector context
#75 of 202
Health Care
What the data says
At $891,000, Immunovant, Inc.'s income tax ranks #128 of 202 in the Health Care sector. Income Tax has increased for 4 consecutive years, from -$358,000 in FY2020 to $891,000 in FY2024.
Based on SEC 10-K filings.
$891,000 in FY2024 with a 5-year CAGR of +55.8%.
Increased from $9,000 to $891,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +55.8%
- 10-Year CAGR
- -
Sector benchmark
#128 of 202 in Health CareTop 63% of 202This company $891.0K Sector average $119.7M
▼
-99.3% below sector average
Key checks
Key Insights
- Immunovant, Inc.'s income tax has grown for 4 consecutive years.
- 5-year CAGR of +55.8%, indicating consistent growth.
- In FY2024, income tax increased 57.1% year-over-year.
- Ranks #75 out of 202 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $891.0K | +57.1% |
| FY2023 | $567.0K | +6200.0% |
| FY2022 | $9.0K | +110.7% |
| FY2021 | -$84.0K | +76.5% |
| FY2020 | -$358.0K | -469.1% |
| FY2019 | $97.0K | +410.5% |
| FY2018 | $19.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026